Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in CADL — Candel Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to CADL Full portfolio

Position in CADL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$336,129
+$214,302 QoQ
Shares Held
32,634
+31.3% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 138 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in CADL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,196,194 across 425 Biotechnology names. CADL ranks #210 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in CADL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $336,129 32,634
2026-03-31 $121,827 24,863
2025-12-31 $122,186 21,626
2025-09-30 $90,953 17,834
2025-06-30 $98,835 19,533
2025-03-31 $80,585 14,263
2024-12-31 $90,497 10,426
2024-09-30 $62,723 9,051
2024-06-30 $120,018 19,358
2024-03-31 $348 221
2023-12-31 $306 209
2023-09-30 $186 203
2023-06-30 $234 186
2023-03-31 $251 186
2022-12-31 $332 186
2022-09-30 $4,578 1,458
2022-06-30 $4,040 1,247
2022-03-31 $17,239 3,387
2021-12-31 $19,776 2,529